# OptMed, Inc.: Form D filings

OptMed, Inc., a biotechnology company in New York, NY, filed 9 Form D notices with the SEC between 2009 and 2015. The latest, on August 11, 2015, reports $200,000 sold of a $500,000 offering to 1 investor.

Find out what OptMed, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20OptMed%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=OptMed%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foptmed-inc-1469988)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20OptMed%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=OptMed%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foptmed-inc-1469988)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 601 LEXINGTON AVENUE, SUITE 5100, New York, NY, 10022
- Phone: (212) 867-4141
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1469988

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 11, 2015 | New notice | $500,000 | $200,000 | $300,000 | 1 | Jul 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998815000002/0001469988-15-000002-index.htm) |
| Mar 17, 2015 | New notice | $400,000 | $200,000 | $200,000 | 3 | Mar 2, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998815000001/0001469988-15-000001-index.htm) |
| Jun 27, 2014 | New notice | $1,500,000 | $75,000 | $1,425,000 | 1 | Jun 26, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998814000001/0001469988-14-000001-index.htm) |
| Jun 11, 2013 | New notice | $1,200,000 | $124,000 | $1,076,000 | 4 | May 30, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998813000001/0001469988-13-000001-index.htm) |
| Aug 22, 2012 | New notice | $2,100,000 | $257,321 | $1,842,679 | 8 | Aug 15, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998812000003/0001469988-12-000003-index.htm) |
| Feb 3, 2012 | New notice | $2,000,000 | $321,849 | $1,678,151 | 4 | Jan 23, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000101905612000107/0001019056-12-000107-index.htm) |
| Apr 29, 2011 | Amendment | $2,600,000 | $600,995 | $1,999,005 | 13 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998811000003/0001469988-11-000003-index.htm) |
| Apr 28, 2011 | New notice | $26,000,000 | $6,009,950 | $19,990,050 | 13 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998811000002/0001469988-11-000002-index.htm) |
| Sep 1, 2009 | New notice | $7,000,000 | $2,000,000 | $5,000,000 | 8 | Aug 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469988/000146998809000001/0001469988-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kevin McKim | Director |  |
| Martin Sands | Director |  |
| Ervin Braun | Executive Officer, Director |  |
| Steven Sands | Director |  |
| Sanket Parekh | Director |  |
| Alain Klapholz | Executive Officer, Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Aug 10, 2015](https://specstream.ai/data/form-d/week/2015-08-10) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what OptMed, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).